New Delhi: Revised maximum retail prices for 1,364 anti-cancer formulations came into effect across India on Monday, with price cuts of up to 96.45 percent following the government's decision to cap trade margins on 137 non-scheduled cancer drugs. The move is expected to save consumers an estimated ₹3,540.38 crore annually.

The National Pharmaceutical Pricing Authority capped trade margins at 30 percent of the maximum retail price, based on recommendations from an expert committee constituted by the Directorate General of Health Services. According to the Ministry of Chemicals and Fertilizers, 85 pharmaceutical companies had reported revised prices for 1,364 formulations covering 121 drugs as of November 8, with 679 brands reporting reductions of more than 50 percent.

Patients can verify the revised prices through the MRP printed on medicine packs, the "Pharma Sahi Daam" mobile application, or the official NPPA website (nppa.gov.in). The ministry stated that no chemist or hospital pharmacy is permitted to charge more than the revised MRP.

Consumers can lodge complaints regarding overcharging or other pricing-related issues through the Pharma Jan Samadhan portal or by contacting the NPPA helpline at 1800-111-255. Hospitals and chemists are required to prominently display the revised price lists on their premises and websites.

Join on Rehaab Online WhatsApp Group (Click here to join the group)